Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.57 USD | -0.09% | -0.13% | +8.61% |
05-16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
05-16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.61% | 3.45B | |
+11.65% | 128B | |
-8.89% | 11.26B | |
+6.26% | 9.28B | |
+35.31% | 5.42B | |
-22.22% | 4.8B | |
-9.60% | 2.8B | |
-12.15% | 2.1B | |
-11.96% | 1.98B | |
-26.31% | 1.71B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Needham Adjusts Price Target on Axonics to $76 From $73, Maintains Buy Rating